[4] Both of these are, mechanistically, more about limiting damage (neuroprotection and vascular/edema effects) than about regenerating lost neurons a distinction that matters for the central comparison, because it suggests BPC-157s CNS story is weighted toward protection and vascular support rather than the progenitor-driven remodeling seen with thymosin beta-4
INDICATIONS SPRYCEL (dasatinib) is indicated for the treatment of adult patients with: SPRYCEL is indicated for the treatment of pediatric patients 1 year of age and older with: Tablet dosing for pediatric patients 1 Tablet dosing is not recommended for patients weighing less than 10 kg
Not medical advice This information is not a substitute for professional medical guidance, diagnosis, or treatment
Some see it as a promising compound, while others are skeptical due to limited human trials
Your clinician will recommend a schedule that aligns with your wellness goals, lifestyle and how your body responds
However, peptide therapy remains an evolving field